Letter of Support to Reduce the Timing Between COVID-19 Vaccine Doses for Patients With Neuromuscular Diseases
The Neuromuscular Disease Network for Canada and MDC together with neurologists, Jesse’s Journey and GBS-CIDP Canada, have submitted a letter to Health Minister Patty Hajdu, Dr. Quach-Thanh, Chair of NACI and each provincial health minister urging them to further nuance the list of those who should be prioritized for their second dose of COVID-19 vaccine by including adults affected by neuromuscular disease.
Read the full press release from MDC here.
Read next...
Advancing Neuromuscular Research: 2025 NMD4C Publications
Our network continues to grow, collaborate, and push the field forward, and these 2025 publications highlight the impact our community is making together
2026 NMD4C Application & Nomination Deadlines
As we start the new year, three important NMD4C opportunities are approaching their deadlines. Members are invited to nominate a researcher or publication for the Annual NMD4C Awards, apply to join the Basic Science Trainee Committee (BSTC), and apply to attend the 2026 NMD4C Basic Research Summer School, taking place June 8–10 under the leadership of Dr. Mireille Khacho. Registration for the summer school is free, with travel and accommodations covered for non‑local trainees.
Announcing the 2026 Neuromuscular Postdoctoral Fellowship Funding Recipients!
Together with Muscular Dystrophy Canada (MDC), we’re excited to share that the 2026 Neuromuscular Postdoctoral Research Fellows have been awarded! This year’s competition provided salary support for two exceptional early‑career scientists to pursue postdoctoral research in Canadian laboratories dedicated to advancing neuromuscular research. Successful applicants will receive $40,000 in funding over a one-year period.